1. Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments
   Rong Biaoxue et al, 2016, Journal of Translational Medicine CrossRef
2. A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019
   Wacili Da et al, 2021, BMC Cancer CrossRef
3. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas
   Karen A. Boehme et al, 2016, International Journal of Oncology CrossRef
4. Decrease in stathmin expression by arsenic trioxide inhibits the proliferation and invasion of osteosarcoma cells via the MAPK signal pathway
   Tao Feng et al, 2017, Oncology Letters CrossRef